{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T10:17:41Z","timestamp":1793614661217,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.atherosclerosis.2024.118562","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T20:52:31Z","timestamp":1723150351000},"page":"118562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["HDL, reverse cholesterol transport, and atherosclerosis: Unravelling the complexity or adding to the confusion?"],"prefix":"10.1016","volume":"397","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6541-8542","authenticated-orcid":false,"given":"Paolo","family":"Parini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2024.118562_bib1","first-page":"1","article-title":"Ueber experimentelle Cholesterol-insteatose und ihre Bedetung fuer die Entstehung einiger pathologischer Processe","volume":"23","author":"Anitschkow","year":"1913","journal-title":"Zentrbl Allg Pathol Phatol Ant"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118562_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/ATVBAHA.120.314050","article-title":"Novel insights from human studies on the role of high-density lipoprotein in mortality and noncardiovascular disease","volume":"41","author":"Madsen","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.118562_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cmet.2016.07.016","article-title":"Beneficial and adverse effects of an LXR agonist on human lipid and lipoprotein metabolism and circulating neutrophils","volume":"24","author":"Kirchgessner","year":"2016","journal-title":"Cell Metabol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.118562_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cvr\/cvu150","article-title":"HDL in innate and adaptive immunity","volume":"103","author":"Catapano","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.118562_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-2275(20)43114-1","article-title":"The plasma lecithins:cholesterol acyltransferase reaction","volume":"9","author":"Glomset","year":"1968","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.118562_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0021-9150(01)00677-3","article-title":"Dynamics of reverse cholesterol transport: protection against atherosclerosis","volume":"161","author":"Sviridov","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118562_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.117578","article-title":"Liver-specific Lxr inhibition represses reverse cholesterol transport in cholesterol-fed mice","volume":"397","author":"Nishida","year":"2024","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118562_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cmet.2006.11.012","article-title":"Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice","volume":"5","author":"Chen","year":"2007","journal-title":"Cell Metabol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.118562_bib9","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.31052","article-title":"Insights from liver-humanized mice on cholesterol lipoprotein metabolism and LXR-agonist pharmacodynamics in humans","volume":"72","author":"Minniti","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.118562_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1567-5688(02)00047-8","article-title":"Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL","volume":"3","author":"Angelin","year":"2002","journal-title":"Atherosclerosis Suppl."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.118562_bib11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/01.ATV.0000060447.25136.1C","article-title":"Is there a need for cholesteryl ester transfer protein inhibition?","volume":"23","author":"Parini","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.118562_bib12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tem.2012.10.004","article-title":"Atherosclerosis: lessons from LXR and the intestine","volume":"24","author":"Bonamassa","year":"2013","journal-title":"Trends Endocrinol. Metabol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.118562_bib13","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/01.CIR.0000026802.79202.96","article-title":"Accumulation of foam cells in liver X receptor-deficient mice","volume":"106","author":"Schuster","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.118562_bib14","first-page":"900","article-title":"Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice","volume":"51","author":"Bischoff","year":"2010","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118562_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0022-2275(20)30180-2","article-title":"BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis","volume":"43","author":"Edwards","year":"2002","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.118562_bib16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1172\/JCI9794","article-title":"Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice","volume":"107","author":"Alberti","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.118562_bib17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1210\/me.2002-0246","article-title":"Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha","volume":"17","author":"Goodwin","year":"2003","journal-title":"Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.118562_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cmet.2010.07.002","article-title":"Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis","volume":"12","author":"Lo","year":"2010","journal-title":"Cell Metabol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024011341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024011341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T09:55:20Z","timestamp":1727690120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024011341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":18,"alternative-id":["S0021915024011341"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118562","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDL, reverse cholesterol transport, and atherosclerosis: Unravelling the complexity or adding to the confusion?","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118562","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117578","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"118562"}}